Jerini, PR Pharma deal

PR Pharma and Jerini's Jerini Ophthalmic Inc. subsidiary will use PR Pharma's drug delivery technologies to develop sustained-release formulations of Jerini's JSM6427 and JPE-1375 to treat age-relate...